ALKS Alkermes PLC

Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.

$21.94  -0.46 (-2.05%)
As of 11/30/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Ireland
IPO date:  02/02/2001
Outstanding shares:  161,705,367
Average volume:  1,270,832
Market cap:   $3,633,519,596
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G01767105
ISIN:        IE00B56GVS15
Sedol:      B3P6D26
Valuation   (See tab for details)
PE ratio:   -39.51
PB ratio:   3.30
PS ratio:   3.22
Return on equity:   -8.36%
Net income %:   -8.12%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy